The Artificial Intelligence In Healthcare Sector segmentation by application delineates five primary use‑cases that together drive the market’s revenue composition. Diagnostics (≈30%) leverages AI algorithms for imaging analysis, pathology, and early disease detection, generating the largest share due to high adoption in radiology and oncology. Treatment Planning (≈25%) applies predictive modeling and simulation to personalize therapeutic regimens, especially in surgery and radiation therapy, contributing a substantial portion of capital expenditures. Drug Discovery (≈20%) utilizes AI for target identification, molecular design, and clinical trial optimization, reflecting strong investment from pharmaceutical firms seeking cost‑efficient pipelines. Patient Monitoring (≈15%) integrates wearable sensors and real‑time analytics to track vital signs and chronic conditions, expanding hospital and home‑care services. Administrative Workflow (≈10%) automates billing, scheduling, and claims processing, offering efficiency gains that, while smaller in absolute spend, are critical for overall system sustainability. The accompanying pie‑chart quantifies these application‑level shares, illustrating their relative impact on the total market size.